CGA M-16

Click here to purchase

This publication is based on FDA’s August 2003 Guidance for Industry Part 11, Electronic Records; Electronic Signatures–Scope and Application and satisfies the criteria of 21 CFR Part 11, § 11.1 (a) “The regulations in this part set forth the criteria under which the agency considers electronic records, electronic signatures, and handwritten signatures executed to electronic records to be trustworthy, reliable, and generally equivalent to paper records and handwritten signatures executed on paper”.

This guideline also harmonizes with PIC/S Guide for good manufacturing practice for medicinal products, Annex 11 “Computerised Systems” (as adopted in Canada).

Product Details

Edition:

2

Published:

02/23/2022

Number of Pages:

16

File Size:

1 file , 380 KB

Note:

This product is unavailable in Belarus, Russia, Ukraine

CGA M-16

Click here to purchase
This guideline is based upon FDA’s August 2003 Guidance for Industry Part 11, Electronic Records; Electronic Signatures—Scope and Application and satisfies the criteria of 21 CFR Part 11, § 11.1 (a) “The regulations in this part set forth the criteria under which the agency considers e-records, e-signatures, and handwritten signatures executed to e-records to be trustworthy, reliable, and generally equivalent to paper records and handwritten signatures executed on paper”.

This guideline also harmonizes with PIC/S Guide for good manufacturing practice for medicinal products, Annex 11 “Computerised Systems” (as adopted in Canada).

Product Details

Edition:

1st

Published:

03/01/2016

Number of Pages:

16

File Size:

1 file , 1000 KB